Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2019 Apr 25;71(6):703–716. doi: 10.1002/acr.23871

Table 2.

Critical and Important Outcomes*

Screening Critical Outcomes:

  • New diagnosis of uveitis

  • New diagnosis of uveitis with ANY ocular complications
Monitoring Critical Outcomes:

  • Loss of control of uveitis

  • New complications due to inflammation


Important Outcomes:

  • Severity/level of inflammation
Treatment Critical Outcomes:

  • Loss of control of uveitis

  • Incidence of loss of control of uveitis

  • Control of uveitis at 1 month and 3 months

  • New ocular glucocorticoid complications (cataracts, glaucoma/increased intraocular pressure, infection)

  • New ocular complications due to inflammation

  • Incident uveitis

  • Recurrence of uveitis


Important Outcomes:

  • Side effects of systemic therapy

  • Time to control of uveitis

  • Time to loss of control of uveitis
*

Vary depending on the recommendation.